Skip to content

Femoral Versus Psoas Continuous Peripheral Nerve Blocks Following Hip Arthroplasty

Femoral Versus Psoas Continuous Peripheral Nerve Blocks Following Hip Arthroplasty

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00967980
Enrollment
50
Registered
2009-08-28
Start date
2009-09-30
Completion date
2010-08-31
Last updated
2010-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthroplasty, Hip Pain

Keywords

pain, Hip Resurfacing, catheter, nerve block, UCSD, hip surgery, psoas, femoral, ambulation, hip flexion, infusion

Brief summary

The purpose of this research study is to determine if the insertion site of a perineural catheter, or tiny tube placed next to the nerves that go to the hip which you will have surgery, affects the amount of pain relief that is experienced after surgery.

Detailed description

To determine the association between perineural catheter location and postoperative analgesia, analgesic requirements, ambulatory distance, and flexion following hip arthroplasty. Primary Hypothesis: Differing the catheter insertion site (femoral vs. psoas compartment) for a perineural local anesthetic infusion is not associated with lower pain scores during the 24-hour period beginning the morning following hip arthroplasty.

Interventions

PROCEDUREFemoral Nerve Block vs. Psoas Compartment Nerve Block

Patients, undergoing hip arthroplasty or hip resurfacing will be randomized to one of two groups: femoral nerve block or psoas compartment nerve block. Patients randomized to femoral nerve block will receive this block prior to surgery. Patients randomized to psoas compartment nerve block will receive this block prior to surgery. Both patients will receive Mepivicaine via catheter prior to surgery and following surgery, Ropivicaine via pain pump.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* primary, unilateral hip arthroplasty or hip resurfacing * age greater than or equal to 18 years * postoperative analgesic plan includes perineural local anesthetic infusion

Exclusion criteria

* morbid obesity (BMI greater than 40) * chronic, high-dose opioid use * history of opioid abuse * pregnancy * incarceration * amu meirp-muscular deficit of the ipsilateral femoral nerve and/or quadriceps muscle * inability to communicate with hospital staff

Design outcomes

Primary

MeasureTime frame
Patient's mean pain score (NRS) during perineural infusion as measured by the nursing staff at UCSD and entered in the computer system.24 hours beginning 7:30am day following surgery

Secondary

MeasureTime frame
Patient's ambulation distance as recorded by therapist (occupational or physical) in the UCSD computer system.3 days following surgery
Hip flexion, in degrees measured with a standard goneometer, as recorded by therapist (occupational or physical) in the UCSD computer system.3 days following surgery
Infusion duration of pain pump, measured on the pump itself in hours and minutes.3 days following surgery
Analgesic used, as reported by nursing staff in the UCSD computer system.3 days following surgery
Surgical/anesthetic adverse events as reported by hospital staffday of surgery and 3 days following
Experiences of patient during the infusion and following, as reported to study staff in a phone conversation, one week following surgery.1 week following surgery
Duration of hospital stay, in hours, as reported in the UCSD computer system.3 days following surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026